Purpura, Thrombocytopenic, Idiopathic: all 521 studies

Page 5 of 6. Open to participants first (158), then studies with results posted, then the rest; newest registration first within each.

• Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP)WithdrawnNCT02642380Phase 4
• Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune ThrombocytopeniaStatus unknownNCT02627417Phase 3
• Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) PatientsStatus unknownNCT02614846Phase 1
• PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITPTerminatedNCT02566603Phase 1/2
• Caffeic Acid Combining High-dose Dexamethasone in Management of ITPCompletedNCT02556814Phase 4
• A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) PatientsStatus unknownNCT02403440Phase 1
• Eltrombopag in Second Line Adult Primary Immune ThrombosytopeniaCompletedNCT02402998Phase 2
• PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITPTerminatedNCT02401061Phase 1/2
• A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in PregnancyCompletedNCT02391272Phase 3
• Caffeic Acid Tablets as a Second-line Therapy for ITPCompletedNCT02351622Phase 3
• An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITPStatus unknownNCT02338414Phase 2
• Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune ThrombocytopeniaCompletedNCT02298075
• Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP)CompletedNCT02287649Not applicable
• Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy SubjectsCompletedNCT02281370Phase 1
• Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in PregnancyStatus unknownNCT02270801Phase 3
• A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）WithdrawnNCT02203422Phase 3
• An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)CompletedNCT02153060Phase 2
• An Investigation of rhTPO With Different Frequencies in the Management of ITPCompletedNCT02139501Phase 3
• A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）WithdrawnNCT02137681Phase 3
• Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration TrainingCompletedNCT02085993
• An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune ThrombocytopeniaCompletedNCT02063789Phase 3
• TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.CompletedNCT02063763
• A Chart Review of Rituximab Plus Repeated Cycles of DexamethasoneTerminatedNCT02050581
• Study of Immune Thrombocytopenia Pathogenesis:CompletedNCT02042560
• Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesCompletedNCT01988506Phase 2
• High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITPWithdrawnNCT01976195Phase 2
• A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013CompletedNCT01974232
• ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITPCompletedNCT01971684
• The International ITP RegistryStatus unknownNCT01970189
• Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.CompletedNCT01933035
• At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
• All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)WithdrawnNCT01882127Phase 3
• The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune ThrombocytopeniaWithdrawnNCT01869049
• Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag TreatmentWithdrawnNCT01864512
• Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITPStatus unknownNCT01805648Phase 3
• Oxidant Status and Effect of Antioxidant in Immune ThrombocytopeniaStatus unknownNCT01763658Phase 2/3
• Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)WithdrawnNCT01734057Phase 3
• rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITPCompletedNCT01734044Phase 3
• Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) PatientsCompletedNCT01730352Phase 2/3
• Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin MimeticsCompletedNCT01727999
• Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune ThrombocytopeniaCompletedNCT01727232
• Low-dose Rituximab Regimens in Chinese Adult Patients With Immune ThrombocytopeniaCompletedNCT01719692Not applicable
• Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic PurpuraCompletedNCT01713855Not applicable
• Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT01713738Phase 1/2
• Efficacy of Rapamycin Therapy With Chronic Immune ThrombocytopeniaCompletedNCT01672151
• Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune ThrombocytopeniaCompletedNCT01668615
• The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune ThrombocytopeniaCompletedNCT01667263Phase 2
• Autoantibody Specificity and Response to IVIG in ITPCompletedNCT01666795
• Eltrombopag and High-dose Dexamethasone as First Line Treatment for ITCompletedNCT01652599Phase 2
• A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia PatientsCompletedNCT01621204Phase 3
• Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.CompletedNCT01618734
• Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)CompletedNCT01610180Phase 2
• MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITPWithdrawnNCT01609452Phase 2/3
• Hemostasis in Patients With Idiopathic Thrombocytopenic PurpuraCompletedNCT01571349
• A Multi-center Study of Low-dose Decitabine for the Treatment of Immune ThrombocytopeniaCompletedNCT01568333Phase 2
• Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune ThrombocytopeniaCompletedNCT01549184
• A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501CompletedNCT01549054Phase 1
• rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITPCompletedNCT01525836Phase 3
• Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP)CompletedNCT01510873
• Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)CompletedNCT01506414Phase 3
• Honey in Chronic Immune ThrombocytopeniaTerminatedNCT01462916
• Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)WithdrawnNCT01443351
• A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.WithdrawnNCT01440361Phase 2
• Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and RomiplostimCompletedNCT01439321
• Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects Comparing the Interactions Between E5501 and Verapamil and Cyclosporine.CompletedNCT01437384Phase 1
• Nexium Capsules Helicobacter Pylori Specific Clinical Experience InvestigationCompletedNCT01435525
• Drug Use Investigation for REVOLADE (ITP)CompletedNCT01416311
• End of EXTEND: Discontinuation of Medication for Patients With Immune ThrombocytopeniaTerminatedNCT01386723
• High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)CompletedNCT01356511Phase 4
• Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy SubjectsCompletedNCT01327872Phase 1
• Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune ThrombocytopeniaWithdrawnNCT01317966
• A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy SubjectsCompletedNCT01289509Phase 1
• Single Incision Versus Standard Laparoscopic SplenectomyWithdrawnNCT01276561Not applicable
• Helicobacter Pylori Immune Thrombocytopenic PurpuraStatus unknownNCT01255332
• The Role of Traditional Chinese Medicine in the Treatment of Chronic Childhood Immune Thrombocytopenia (ITP)TerminatedNCT01226524Phase 2/3
• Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)Status unknownNCT01162941Phase 2
• Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITPCompletedNCT01107951Phase 2
• The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.Status unknownNCT01101295
• Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food EffectCompletedNCT01072162Phase 1
• Promacta Pregnancy RegistryCompletedNCT01064336
• The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune DisordersCompletedNCT00960713
• The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00909077Phase 3
• Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With EltrombopagCompletedNCT00888901Phase 4
• Effects of Long-term Dosing of AMG 531 on Bone Marrow MorphologyCompletedNCT00861224
• Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) PatientsCompletedNCT00860600Phase 2
• Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune CytopeniasCompletedNCT00749112Phase 2/3
• Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)CompletedNCT00718692Phase 2
• Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of EltrombopagCompletedNCT00688272Phase 1
• Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic PurpuraCompletedNCT00657410Phase 3
• LENS - Long-term Eltrombopag Observational StudyCompletedNCT00643929
• Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment ContinuationCompletedNCT00621894Phase 2
• Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITPTerminatedNCT00571467Phase 1
• Study of Veltuzumab (hA20) at Different Doses in Patients With ITPTerminatedNCT00547066Phase 1/2
• Eltrombopag Taste Testing in Healthy Adult VolunteersCompletedNCT00487968Phase 1
• Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic PurpuraCompletedNCT00486421Early Phase 1
• Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic PurpuraCompletedNCT00467571Phase 4
• High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITPCompletedNCT00451594Phase 3
• Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal ImpairmentCompletedNCT00442871Phase 1
• A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.CompletedNCT00376077Phase 3
• Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)CompletedNCT00372892Phase 2

← Purpura, Thrombocytopenic, Idiopathic overview